Healthcare IT News May 19, 2021
Kat Jercich

The cyber risk platform Black Kite also found that vendors – especially data management platforms – can expose their business partners to vulnerabilities.

The cyber risk platform Black Kite released a new report this week finding that one in 10 global pharmaceutical manufacturers are at a high risk of suffering a ransomware attack.

The report, published on Tuesday, evaluated the cybersecurity posture of the 200 largest global pharmaceutical companies and 166 associated third-party vendors.

“We have seen how ransomware attackers can shut down a gasoline pipeline in the past week. Imagine if a ransomware attack halted a manufactured COVID-19 vaccine hostage or stopped the production of vital chemotherapy drugs,” said Bob Maley, Black Kite’s chief security officer, in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Cybersecurity, Health IT, Pharma, Pharma / Biotech, Survey / Study, Technology, Trends
AI Identifies New Potential Treatments For Parkinson’s Disease
It's Not Just Congress. There's Plenty of State-Level Action on PBMs, Drug Costs and Prices | AMCP 2024
On the Front Lines: Pharmacists' Role in Combating America's Opioid Epidemic
Ultimovacs lays off 40% in wake of cancer vaccine's phase 2 fail
How to Include Patients When Measuring Value | AMCP 2024

Share This Article